JW Pharmaceutical (XKRX:001060) Net Issuance of Debt : ₩-78,110 Mil (TTM As of Mar. 2024)

View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. JW Pharmaceutical's net issuance of debt for the three months ended in Mar. 2024 was ₩-18,968 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-78,110 Mil.

JW Pharmaceutical Net Issuance of Debt Historical Data

The historical data trend for JW Pharmaceutical's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Net Issuance of Debt Chart

JW Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Issuance of Debt

Get a 7-Day Free Trial

9,700.73

-4,625.04

36,960.38

-36,523.30

-28,189.80

JW Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Issuance of Debt	Get a 7-Day Free Trial															30,952.72	-6,368.17	-11,988.38	-40,785.97	-18,967.85

JW Pharmaceutical Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-78,110 Mil.

JW Pharmaceutical Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical (XKRX:001060) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Net Issuance of Debt

Traded in Other Exchanges

001067:Korea 001065.PFD:Korea

Address

2477, Nambusunhwan-ro, Seocho-gu, KOR

Website

https://www.jw-pharma.co.kr

JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines